Retrophin Inc. (RTRX): Scopia Capital Adds To Its Stake

Page 7 of 12

Page 7 of 12 – SEC Filing

(c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
(d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) x An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g) x A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
(i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
(k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:
Item 4. Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
Scopia Capital Management LP
(a) Amount beneficially owned:

3,811,821

(b) Percent of class:

10.4%

(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote               0,
(ii) Shared power to vote or to direct the vote 3,811,821,
(iii) Sole power to dispose or to direct the disposition of               0,
(iv) Shared power to dispose or to direct the disposition of 3,811,821.

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)

Page 7 of 12